Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:48 pm Unchanged | 2025-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Armistice Capital, LLC | 194,132 9.990% | 0 (Unchanged) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Armistice Capital, LLC | 194,132 9.990% | 194,132 (New Position) | Filing History |
| 2026-02-13 4:38 pm Purchase | 2025-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Mitchell P. Kopin | 91,537 4.990% | 47,142 (+106.19%) | Filing History |
| 2026-02-05 9:43 pm Purchase | 2026-02-05 | 13G | Bluejay Diagnostics, Inc. BJDX | Northstrive Fund II LP | 35,500 5.010% | 35,500 (New Position) | Filing History |
| 2026-02-05 9:42 pm Purchase | 2026-02-05 | 13G | Bluejay Diagnostics, Inc. BJDX | Braeden Lichti | 35,500 5.010% | 35,500 (New Position) | Filing History |
| 2025-10-16 4:50 pm Purchase | 2025-10-10 | 13G | Bluejay Diagnostics, Inc. BJDX | Mitchell P. Kopin | 44,395 9.990% | 44,395 (New Position) | Filing History |
| 2025-02-14 4:59 pm Purchase | 2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | L1 Capital Global Opportunities Master Fund, Ltd. | 55,313 0.820% | 52,095 (+1619.14%) | Filing History |
| 2025-02-14 11:48 am Purchase | 2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Anson Funds Management LP | 91,988 1.400% | 90,391 (+5662.18%) | Filing History |
| 2025-01-03 3:31 pm Purchase | 2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT LLC | 6,897 4.900% | 6,786 (+6116.33%) | Filing History |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | Bluejay Diagnostics, Inc. BJDX | Anson Funds Management LP | 1,596 5.100% | 1,596 (New Position) | Filing History |
| 2024-11-14 3:54 pm Purchase | 2024-09-30 | 13G | Bluejay Diagnostics, Inc. BJDX | Armistice Capital, LLC | 1,738 4.990% | 1,738 (New Position) | Filing History |
| 2024-07-03 4:01 pm Purchase | 2024-06-27 | 13G | Bluejay Diagnostics, Inc. BJDX | L1 Capital Global Opportunities Master Fund, Ltd. | 3,217 9.990% | 3,217 (New Position) | Filing History |
| 2024-02-14 3:29 pm Purchase | 2023-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Armistice Capital, LLC | 122 9.990% | 122 (New Position) | Filing History |
| 2024-01-03 4:44 pm Purchase | 2023-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT LLC | 111 11.000% | 81 (+264.83%) | Filing History |
| 2022-01-04 4:00 pm Sale | 2021-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT LLC | 30 11.000% | -9 (-22.92%) | Filing History |
| 2021-12-22 5:21 pm Purchase | 2021-11-15 | 13D | Bluejay Diagnostics, Inc. BJDX | Wurth Douglas Clark | 110 27.260% | 110 (New Position) | Filing History |
| 2021-12-22 5:18 pm Purchase | 2021-11-15 | 13D | Bluejay Diagnostics, Inc. BJDX | Dey Indranil | 142 35.760% | 142 (New Position) | Filing History |
| 2021-11-17 07:52 am Purchase | 2021-11-10 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT LLC | 39 11.000% | 39 (New Position) | Filing History |